214 related articles for article (PubMed ID: 30735573)
1. Predicting diagnosis of Parkinson's disease: A risk algorithm based on primary care presentations.
Schrag A; Anastasiou Z; Ambler G; Noyce A; Walters K
Mov Disord; 2019 Apr; 34(4):480-486. PubMed ID: 30735573
[TBL] [Abstract][Full Text] [Related]
2. Prediagnostic presentations of Parkinson's disease in primary care: a case-control study.
Schrag A; Horsfall L; Walters K; Noyce A; Petersen I
Lancet Neurol; 2015 Jan; 14(1):57-64. PubMed ID: 25435387
[TBL] [Abstract][Full Text] [Related]
3. Performance of the Movement Disorders Society criteria for prodromal Parkinson's disease: A population-based 10-year study.
Mahlknecht P; Gasperi A; Djamshidian A; Kiechl S; Stockner H; Willeit P; Willeit J; Rungger G; Poewe W; Seppi K
Mov Disord; 2018 Mar; 33(3):405-413. PubMed ID: 29436728
[TBL] [Abstract][Full Text] [Related]
4. PREDICT-PD: An online approach to prospectively identify risk indicators of Parkinson's disease.
Noyce AJ; R'Bibo L; Peress L; Bestwick JP; Adams-Carr KL; Mencacci NE; Hawkes CH; Masters JM; Wood N; Hardy J; Giovannoni G; Lees AJ; Schrag A
Mov Disord; 2017 Feb; 32(2):219-226. PubMed ID: 28090684
[TBL] [Abstract][Full Text] [Related]
5. Identification of Prodromal Presentations of Parkinson's Disease among Primary Care Outpatients in Germany.
Bohlken J; Schrag A; Riedel-Heller S; Kostev K
Neuroepidemiology; 2022; 56(1):41-49. PubMed ID: 34724667
[TBL] [Abstract][Full Text] [Related]
6. The Emergence and Progression of Motor Dysfunction in Individuals at Risk of Parkinson's Disease.
Simonet C; Mahlknecht P; Marini K; Seppi K; Gill A; Bestwick JP; Lees AJ; Giovannoni G; Schrag A; Noyce AJ
Mov Disord; 2023 Sep; 38(9):1636-1644. PubMed ID: 37317903
[TBL] [Abstract][Full Text] [Related]
7. Application of the movement disorder society prodromal Parkinson's disease research criteria in 2 independent prospective cohorts.
Pilotto A; Heinzel S; Suenkel U; Lerche S; Brockmann K; Roeben B; Schaeffer E; Wurster I; Yilmaz R; Liepelt-Scarfone I; von Thaler AK; Metzger FG; Eschweiler GW; Postuma RB; Maetzler W; Berg D
Mov Disord; 2017 Jul; 32(7):1025-1034. PubMed ID: 28509336
[TBL] [Abstract][Full Text] [Related]
8. Assessment of Risk Factors and Early Presentations of Parkinson Disease in Primary Care in a Diverse UK Population.
Simonet C; Bestwick J; Jitlal M; Waters S; Ben-Joseph A; Marshall CR; Dobson R; Marrium S; Robson J; Jacobs BM; Belete D; Lees AJ; Giovannoni G; Cuzick J; Schrag A; Noyce AJ
JAMA Neurol; 2022 Apr; 79(4):359-369. PubMed ID: 35254398
[TBL] [Abstract][Full Text] [Related]
9. Application of a Simple Parkinson's Disease Risk Score in a Longitudinal Population-Based Cohort.
Marini K; Mahlknecht P; Tutzer F; Stockner H; Gasperi A; Djamshidian A; Willeit P; Kiechl S; Willeit J; Rungger G; Noyce AJ; Schrag A; Poewe W; Seppi K
Mov Disord; 2020 Sep; 35(9):1658-1662. PubMed ID: 32491231
[TBL] [Abstract][Full Text] [Related]
10. Risk of Parkinson's disease in people aged ≥50 years with new-onset anxiety: a retrospective cohort study in UK primary care.
Bazo-Alvarez JC; Nimmons D; Walters K; Petersen I; Schrag A
Br J Gen Pract; 2024 Jul; 74(744):e482-e488. PubMed ID: 38514045
[TBL] [Abstract][Full Text] [Related]
11. Optimizing odor identification testing as quick and accurate diagnostic tool for Parkinson's disease.
Mahlknecht P; Pechlaner R; Boesveldt S; Volc D; Pinter B; Reiter E; Müller C; Krismer F; Berendse HW; van Hilten JJ; Wuschitz A; Schimetta W; Högl B; Djamshidian A; Nocker M; Göbel G; Gasperi A; Kiechl S; Willeit J; Poewe W; Seppi K
Mov Disord; 2016 Sep; 31(9):1408-13. PubMed ID: 27159493
[TBL] [Abstract][Full Text] [Related]
12. Orthostatic Hypotension: A Prodromal Marker of Parkinson's Disease?
Dommershuijsen LJ; Heshmatollah A; Mattace Raso FUS; Koudstaal PJ; Ikram MA; Ikram MK
Mov Disord; 2021 Jan; 36(1):164-170. PubMed ID: 32965064
[TBL] [Abstract][Full Text] [Related]
13. Prodromal Parkinson's disease as defined per MDS research criteria in the general elderly community.
Mahlknecht P; Gasperi A; Willeit P; Kiechl S; Stockner H; Willeit J; Rungger G; Sawires M; Nocker M; Rastner V; Mair KJ; Hotter A; Poewe W; Seppi K
Mov Disord; 2016 Sep; 31(9):1405-8. PubMed ID: 27273736
[TBL] [Abstract][Full Text] [Related]
14. Validation of the MDS research criteria for prodromal Parkinson's disease: Longitudinal assessment in a REM sleep behavior disorder (RBD) cohort.
Fereshtehnejad SM; Montplaisir JY; Pelletier A; Gagnon JF; Berg D; Postuma RB
Mov Disord; 2017 Jun; 32(6):865-873. PubMed ID: 28429825
[TBL] [Abstract][Full Text] [Related]
15. Validation of the MDS clinical diagnostic criteria for Parkinson's disease.
Postuma RB; Poewe W; Litvan I; Lewis S; Lang AE; Halliday G; Goetz CG; Chan P; Slow E; Seppi K; Schaffer E; Rios-Romenets S; Mi T; Maetzler C; Li Y; Heim B; Bledsoe IO; Berg D
Mov Disord; 2018 Oct; 33(10):1601-1608. PubMed ID: 30145797
[TBL] [Abstract][Full Text] [Related]
16. Development and validation of prognostic survival models in newly diagnosed Parkinson's disease.
Macleod AD; Dalen I; Tysnes OB; Larsen JP; Counsell CE
Mov Disord; 2018 Jan; 33(1):108-116. PubMed ID: 28976022
[TBL] [Abstract][Full Text] [Related]
17. Application of the Movement Disorder Society prodromal criteria in healthy G2019S-LRRK2 carriers.
Mirelman A; Saunders-Pullman R; Alcalay RN; Shustak S; Thaler A; Gurevich T; Raymond D; Mejia-Santana H; Orbe Reilly M; Ozelius L; Clark L; Gana-Weisz M; Bar-Shira A; Orr-Utreger A; Bressman SB; Marder K; Giladi N;
Mov Disord; 2018 Jul; 33(6):966-973. PubMed ID: 29603409
[TBL] [Abstract][Full Text] [Related]
18. A Prospective Validation of the Updated Movement Disorders Society Research Criteria for Prodromal Parkinson's Disease.
Giagkou N; Maraki MI; Yannakoulia M; Kosmidis MH; Dardiotis E; Hadjigeorgiou GM; Sakka P; Ntanasi E; Anastasiou CA; Xiromerisiou G; Stefanis L; Scarmeas N; Stamelou M
Mov Disord; 2020 Oct; 35(10):1802-1809. PubMed ID: 32567751
[TBL] [Abstract][Full Text] [Related]
19. Prediction of depression and anxiety via patient-assessed tremor severity, not physician-reported motor symptom severity, in patients with Parkinson's disease or essential tremor who have undergone deep brain stimulation.
Achey RL; Yamamoto E; Sexton D; Hammer C; Lee BS; Butler RS; Thompson NR; Nagel SJ; Machado AG; Lobel DA
J Neurosurg; 2018 Dec; 129(6):1562-1571. PubMed ID: 29473781
[TBL] [Abstract][Full Text] [Related]
20. Frailty and Prodromal Parkinson's Disease: Results From the HELIAD Study.
Ntanasi E; Maraki M; Yannakoulia M; Stamelou M; Xiromerisiou G; Kosmidis MH; Dardiotis E; Hadjigeorgiou G; Sakka P; Gargalionis A; Patas K; Chatzipanagiotou S; Charisis S; Stefanis L; Scarmeas N
J Gerontol A Biol Sci Med Sci; 2021 Mar; 76(4):622-629. PubMed ID: 32761172
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
